Search results for "Infections"
MKSAP Quiz: Cough, rhinorrhea, and wheezing for 3 weeks
A 23-year-old man is evaluated for cough, rhinorrhea, and wheezing of 3 weeks' duration. He has no fevers, chills, or chest pain and no history of asthma or allergies. He is a pastry chef and notes that his symptoms improve on nonworking weekends. Following a physical exam and other tests, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2024/01/02/3.htm
2 Jan 2024
OUD risk tests, gene therapies for sickle cell approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/02/oud-risk-tests-gene-therapies-for-sickle-cell-approved.htm
1 Feb 2024
Certain factors associated with higher mortality risk in invasive group B strep infection
In a study of patients with invasive group B Streptococcus infections, all-cause 30-day mortality was highest for those with peritonitis and pneumonia or empyema and lowest among those with osteomyelitis or joint infection.
https://immattersacp.org/weekly/archives/2020/01/07/4.htm
7 Jan 2020
Monkeypox: 5 key points
An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://immattersacp.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis
The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://immattersacp.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022
New research on booster doses, breakthrough infections, long-term COVID-19 symptoms
A vaccine booster significantly reduced risk of severe disease or death from COVID-19, full vaccination provided more protection than previous infection, many patients reporting persistent symptoms did not have antibodies to SARS-CoV-2, and a trial of outpatient treatment was ineffective, recent studies found.
https://immattersacp.org/weekly/archives/2021/11/09/1.htm
9 Nov 2021
After splenectomy, clots join infection as potential risks
Fewer splenectomies are being done, but thromboembolic disease afterward is now more recognized and therefore being diagnosed more frequently.
https://immattersacp.org/archives/2017/04/splenectomy.htm
1 Apr 2017
CDC publishes guidance on testing for flu, COVID-19
Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023